mechanism of glp-1 receptor agonists Mechanisms Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation Mechanism of action for GLP-1R

Description

Ca 2+ imaging was performed one day after transient transfection

PMID 27142267

Although the ELIXA studythe only CVD outcome trial of GLP-1 RAs published to datereported a neutral cardiovascular effect of lixisenatide, the potential cardiovascular benefits of GLP-1 RAs should not be overlooked, because high-risk subjects with established CVD were recruited in this study to delineate its cardiovascular safety within a short-term period

2024;385:e078225

1 READ MORE: GLP-1 Agonists Associated with Doubled Risk of Neovascular AMD, Study Finds NAION moves the discussion beyond the retina A 2024 matched cohort study reporting increased NAION incidence among semaglutide-prescribed patients drew wide attention across ophthalmology, prompting debate over whether the association reflects a true optic nerve safety signal or the underlying vascular risk profiles of diabetic and obese populations